Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1APD334 L-arginine
(D02982)
2件: Arginine,
L-arginine
3件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--1件: 97 💬
2AR401959 L-arginine
(D02982)
2件: Arginine,
L-arginine
3件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--3件: 96, 97, 98 💬
3Arginine
(D02982)
1件: Arginine3件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--16件: 2, 21, 46, 57, 58, 67, 72, 96, 97, 98, 113, 210, 223, 225, 251, 299 💬
4Arginine and citrulline supplementations
(D02982)
2件: Arginine,
Citrulline
5件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride ,
L-Citrulline ,
Citrulline malate 💬
--1件: 21 💬
5Diagnostic Test: Deamino Arginine Vasopressin (dDAVP)
(D02982)
2件: Arginine,
Vasopressin
4件: Vasopressin ,
Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
3件: AVPR1A,
AVPR1B,
AVPR2 💬
6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 225 💬
6Etrasimod L-arginine
(D02982)
3件: Arginine,
Etrasimod,
L-arginine
5件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride ,
Etrasimod ,
Etrasimod arginine 💬
3件: S1PR1,
S1PR4,
S1PR5 💬
4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 96, 97, 98 💬
7EtrasimodProduct Code: APD334Pharmaceutical Form: TabletINN or Proposed INN: etrasimod L-arginineCAS Number: 1206123-97-8Current Sponsor code: APD334 L-arginine
(D02982)
3件: Arginine,
Etrasimod,
L-arginine
5件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride ,
Etrasimod ,
Etrasimod arginine 💬
3件: S1PR1,
S1PR4,
S1PR5 💬
4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 97 💬
8EtrasimodProduct Code: APD334Pharmaceutical Form: TabletINN or Proposed INN: etrasimod L-arginineCAS Number: 1206123-97-8Current Sponsor code: APD334 L-arginine PF-07915503-94 (L-arginine salt)Other descriptive name: AR401959 L-arginineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2-
(D02982)
3件: Arginine,
Etrasimod,
L-arginine
5件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride ,
Etrasimod ,
Etrasimod arginine 💬
3件: S1PR1,
S1PR4,
S1PR5 💬
4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 97 💬
9L-Arginine
(D02982)
2件: Arginine,
L-arginine
3件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--10件: 2, 21, 46, 67, 96, 97, 98, 113, 223, 299 💬
10Measure of arginine-stimulated copeptin
(D02982)
1件: Arginine3件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--2件: 72, 225 💬
11Ng-monomethyl-L-arginine (drug)
(D02982)
2件: Arginine,
L-arginine
3件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--2件: 67, 223 💬
12Peridopril arginine
(D02982)
1件: Arginine3件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--1件: 57 💬
13PERINDOPRIL ARGININE
(D02982)
2件: Arginine,
Perindopril
6件: Perindopril erbumine ,
Arginine hydrochloride ,
Arginine (D02982),
Perindopril ,
Arginine hydrochloride ,
Perindopril arginine 💬
1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬2件: 57, 58 💬
14PF-07915503-94 (L-arginine salt)Other descriptive name: AR401959 L-arginineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2-
(D02982)
2件: Arginine,
L-arginine
3件: Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
--1件: 97 💬
15Vasopressin, Arginine
(D02982)
2件: Arginine,
Vasopressin
4件: Vasopressin ,
Arginine hydrochloride ,
Arginine (D02982),
Arginine hydrochloride 💬
3件: AVPR1A,
AVPR1B,
AVPR2 💬
6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 210 💬